Last reviewed · How we verify
NCT06872723
CPRIT: Patient Adherence to Lung Cancer Screening
trial testing Lung Cancer Screening in Lung Cancer Screening in 340 participants. Currently enrolling.
28 February 2029
Quick facts
| Lead sponsor | M.D. Anderson Cancer Center |
|---|---|
| Status | Recruiting now |
| Study type | OBSERVATIONAL |
| Enrollment | 340 |
| Start date | 21 March 2025 |
| Primary completion | 28 February 2029 |
| Estimated completion | 28 February 2031 |
| Sites | 1 location across United States |
Drugs / interventions tested
- Lung Cancer Screening
Conditions studied
- Lung Cancer Screening — all drugs for Lung Cancer Screening →
Sponsor
M.D. Anderson Cancer Center — full company profile →
Who can join
Adults 50 to 80, any sex, with Lung Cancer Screening. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
To understand participants' barriers to lung cancer screening and their experience with scheduling lung cancer screening.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT06872723
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Lung Cancer Screening
Trials testing the same drug.
- NCT07220356 — C-Raven, a Virtual Tobacco Cessation Intervention in Residency Clinics · Phase 4 · recruiting
- NCT06545669 — C-Raven, a Virtual Tobacco Cessation Intervention in the Community · Phase 4 · completed
- NCT06289192 — Testing C-Raven, a Virtual Tobacco Cessation Intervention, in the Community · Phase 4 · completed
- NCT04409444 — Manchester Lung Health Study · unknown
Other recruiting trials for Lung Cancer Screening
Currently open trials in the same condition.
- NCT05747443 — Multilevel Interventions to Increase Adherence to Lung Cancer Screening · NA · active not recruiting
- NCT05630950 — LDCT-SC-FI Low-dose CT Screening for Lung Cancer · NA · active not recruiting
- NCT05195385 — Lung Cancer Screening With Low-dose CT Scan in Women : Implementation Study · NA · recruiting
- NCT06451029 — Prevention of Smoking Related Diseases · recruiting
- NCT04691297 — Digitally Enhanced Smoking Cessation for High Risk Smokers · NA · active not recruiting
Other M.D. Anderson Cancer Center trials
Trials by the same sponsor.
- NCT07053020 — A Phase 1b/2 Open-label, Dose-ranging Safety and Efficacy Study of Oral Cladribine in Patients With Acute Myeloid Leukem · Phase 1, PHASE2 · not yet recruiting
- NCT07052994 — A Phase Ia/Ib Trial of Revumenib Combined With Cytarabine, Daunorubicin, and Gemtuzumab Ozogamicin (GO) in Frontline and · Phase 1 · not yet recruiting
- NCT07137481 — Phase II Study of CD5 CAR Engineered IL15-transduced Cord Blood-derived NK Cells in Conjunction With Lymphodepleting Che · Phase 2 · not yet recruiting
- NCT07162480 — Phase II Trial of Puxitatug Samrotecan (AZD8205) in Advanced, Recurrent or Metastatic (R/M) Aggressive Adenoid Cystic Ca · Phase 2 · not yet recruiting
- NCT07076498 — Engineered HSV-1 M032 for the Treatment of Children and Adults With Newly Diagnosed Diffuse Midline Glioma After Standar · Phase 1 · not yet recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT06872723 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by M.D. Anderson Cancer Center
- Last refreshed: 2 April 2025
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06872723.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing